Cytek Biosciences

Cytek Biosciences

CTKB· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -22.2% in FY2025

Wenbin Jiang, Ph.D. is the CEO of Cytek Biosciences and was paid $5.1M in FY2025 (Dec), down 16%.

Pay$100 in the stock at the end of FY21 → $31
CEO pay is from each Cytek Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1Wenbin Jiang, Ph.D.FY2025
  2. 2William McCombeFY2025
  3. 3Valerie BarnettFY2025
  4. 4Ming Yan, Ph.D.FY2025
  5. 5Philippe Busque, Ph.D.FY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Cytek Biosciences paid its 5 named executives $12.2M in total in FY2025 (Dec). CEO Wenbin Jiang, Ph.D. was paid $5.1M of that.

Name
Wenbin Jiang, Ph.D.Chief Executive Officer and President
William McCombeChief Financial OfficerNot disclosed
Valerie BarnettChief Legal Officer and Corporate Secretary
Ming Yan, Ph.D.Chief Technology OfficerNot disclosed
Philippe Busque, Ph.D.Senior Vice President, Global Sales and ServicesNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers16

See all

The FY2025 (Dec) proxy of Cytek Biosciences names 16 peer companies for pay. Among Cytek Biosciences and these peers, CEO pay was 8th highest of 9 and total shareholder return was 6th highest of 9.

8th highest of 9in Cytek Biosciences and its pay peers, FY2025 (Dec) by CEO pay:

$4.3M$13.8M

6th highest of 9in Cytek Biosciences and its pay peers, FY2025 (Dec) by total shareholder return:

$7$86

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board2

See all
  • Deborah NeffLead independent director · 3 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive
  • Michael HolderDirector · 1 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. Pay
    Cytek Biosciences CFO pay rose 46% to $2.5M. The stock fell 22% in FY2025 (Dec).
    DEF 14A
  2. Pay
    Cytek Biosciences CEO pay fell 16% to $5.1M. The stock fell 22% in FY2025 (Dec).
    DEF 14A
  3. Pay
    Cytek Biosciences CTO pay fell 21% to $1.5M. The stock fell 22% in FY2025 (Dec).
    DEF 14A
  4. Pay
    Cytek Biosciences CEO pay rose 23% to $6.1M. The stock fell 29% in FY2024 (Dec).
    DEF 14A
  5. Pay
    Cytek Biosciences CEO pay fell 19% to $3.9M. The stock fell 37% in FY2022 (Dec).
    DEF 14A
  6. Pay
    Cytek Biosciences General counsel pay rose 29% to $2.4M. The stock fell 29% in FY2024 (Dec).
    DEF 14A
  7. Pay
    Cytek Biosciences CTO pay fell 44% to $1.5M. The stock fell 37% in FY2022 (Dec).
    DEF 14A
  8. Board
    Michael Holder joined the board of Cytek Biosciences. Michael Holder now sits on 2 public boards.
    3
  9. Pay
    Cytek Biosciences CEO pay rose 26% to $4.9M. The stock fell 11% in FY2023 (Dec).
    DEF 14A
  10. Pay
    Cytek Biosciences General counsel pay rose 32% to $1.9M. The stock fell 11% in FY2023 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 28, 2026FY2025
Annual report10-KFeb 26, 2026FY2025
Proxy statementDEF 14AApr 28, 2025FY2024
Annual report10-KFeb 28, 2025FY2024
Proxy statementDEF 14AApr 25, 2024FY2023
Annual report10-KMar 13, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data